Frontiers in Pharmacology (Mar 2022)
Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
- Nuria Carballo,
- Nuria Carballo,
- Enric Garcia-Alzórriz,
- Olivia Ferrández,
- Olivia Ferrández,
- María Eugenia Navarrete-Rouco,
- Xavier Durán-Jordà,
- Carolina Pérez-García,
- Jordi Monfort,
- Jordi Monfort,
- Francesc Cots,
- Santiago Grau,
- Santiago Grau
Affiliations
- Nuria Carballo
- Pharmacy Department, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Nuria Carballo
- Universitat Autònoma de Barcelona, Barcelona, Spain
- Enric Garcia-Alzórriz
- Management Control Department, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Olivia Ferrández
- Pharmacy Department, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Olivia Ferrández
- Universitat Autònoma de Barcelona, Barcelona, Spain
- María Eugenia Navarrete-Rouco
- Pharmacy Department, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Xavier Durán-Jordà
- Methodology and Biostatistics Support Unit, Institute Hospital del Mar for Medical Research (IMIM), Barcelona, Spain
- Carolina Pérez-García
- Department of Rheumatology, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Jordi Monfort
- Universitat Autònoma de Barcelona, Barcelona, Spain
- Jordi Monfort
- Department of Rheumatology, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Francesc Cots
- Management Control Department, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Santiago Grau
- Pharmacy Department, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain
- Santiago Grau
- Universitat Autònoma de Barcelona, Barcelona, Spain
- DOI
- https://doi.org/10.3389/fphar.2022.867017
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords